Inve India ▾
NONOCIL

NOCIL Q2 FY26 results (Jul–Sep 2025) and concall

Chemicals · Concall AI · Call held 3 Nov 2025

NOCIL reported a challenging quarter, navigating significant headwinds from import dumping and US tariffs. While the company achieved a 4% sequential volume growth, this was overshadowed by severe pricing pressure, leading to a decline in revenue and profitability. Management is focused on cost-saving initiatives, pursuing anti-dumping measures to level the playing field, and progressing on its Dahej capex, which remains on track for H1 CY26 commissioning. The outlook remains cautious, with exports expected to be choppy and the domestic market's recovery contingent on the outcome of regulatory

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q2 FY26: revenue down 11.6%, net profit down 71.4% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue363 318 340 336 321 −12%
EBITDA38 24 34 31 22 −42%
Net profit42 13 21 17 12 −71%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.